Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027

Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sickle Cell Anemia
1.2.3 Sickle Beta Thalassemia
1.2.4 Sickle Hemoglobin C Disease
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatment Market Perspective (2016-2027)
2.2 Sickle Cell Disease Treatment Growth Trends by Regions
2.2.1 Sickle Cell Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle Cell Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Sickle Cell Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Sickle Cell Disease Treatment Industry Dynamic
2.3.1 Sickle Cell Disease Treatment Market Trends
2.3.2 Sickle Cell Disease Treatment Market Drivers
2.3.3 Sickle Cell Disease Treatment Market Challenges
2.3.4 Sickle Cell Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Sickle Cell Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Treatment Revenue
3.4 Global Sickle Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2020
3.5 Sickle Cell Disease Treatment Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Treatment Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Sickle Cell Disease Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sickle Cell Disease Treatment Market Size (2016-2027)
6.2 North America Sickle Cell Disease Treatment Market Size by Type
6.2.1 North America Sickle Cell Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Sickle Cell Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Sickle Cell Disease Treatment Market Size by Type (2016-2027)
6.3 North America Sickle Cell Disease Treatment Market Size by Application
6.3.1 North America Sickle Cell Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Sickle Cell Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Sickle Cell Disease Treatment Market Size by Application (2016-2027)
6.4 North America Sickle Cell Disease Treatment Market Size by Country
6.4.1 North America Sickle Cell Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Sickle Cell Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatment Market Size (2016-2027)
7.2 Europe Sickle Cell Disease Treatment Market Size by Type
7.2.1 Europe Sickle Cell Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Sickle Cell Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Sickle Cell Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Sickle Cell Disease Treatment Market Size by Application
7.3.1 Europe Sickle Cell Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Sickle Cell Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Sickle Cell Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Sickle Cell Disease Treatment Market Size by Country
7.4.1 Europe Sickle Cell Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Sickle Cell Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Treatment Market Size (2016-2027)
9.2 Latin America Sickle Cell Disease Treatment Market Size by Type
9.2.1 Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Sickle Cell Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Sickle Cell Disease Treatment Market Size by Application
9.3.1 Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Sickle Cell Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Sickle Cell Disease Treatment Market Size by Country
9.4.1 Latin America Sickle Cell Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Sickle Cell Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Sickle Cell Disease Treatment Introduction
11.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle Cell Disease Treatment Introduction
11.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Sickle Cell Disease Treatment Introduction
11.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.5.5 Baxter Recent Development
11.6 Emmaus Life Sciences
11.6.1 Emmaus Life Sciences Company Details
11.6.2 Emmaus Life Sciences Business Overview
11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
11.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.6.5 Emmaus Life Sciences Recent Development
11.7 Bluebird bio
11.7.1 Bluebird bio Company Details
11.7.2 Bluebird bio Business Overview
11.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
11.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.7.5 Bluebird bio Recent Development
11.8 Blood Therapeutics
11.8.1 Blood Therapeutics Company Details
11.8.2 Blood Therapeutics Business Overview
11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
11.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.8.5 Blood Therapeutics Recent Development
11.9 Sangamo Therapeutics
11.9.1 Sangamo Therapeutics Company Details
11.9.2 Sangamo Therapeutics Business Overview
11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
11.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.9.5 Sangamo Therapeutics Recent Development
11.10 Acceleron Pharma
11.10.1 Acceleron Pharma Company Details
11.10.2 Acceleron Pharma Business Overview
11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
11.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.10.5 Acceleron Pharma Recent Development
11.11 Arena Pharmaceuticals
11.11.1 Arena Pharmaceuticals Company Details
11.11.2 Arena Pharmaceuticals Business Overview
11.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.11.5 Arena Pharmaceuticals Recent Development
11.12 Alnylam Pharmaceuticals
11.12.1 Alnylam Pharmaceuticals Company Details
11.12.2 Alnylam Pharmaceuticals Business Overview
11.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.12.5 Alnylam Pharmaceuticals Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Sickle Cell Disease Treatment Introduction
11.13.4 Sanofi Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 CRISPR Therapeutics
11.14.1 CRISPR Therapeutics Company Details
11.14.2 CRISPR Therapeutics Business Overview
11.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Introduction
11.14.4 CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.14.5 CRISPR Therapeutics Recent Development
11.15 Vertex Pharmaceuticals, Inc.
11.15.1 Vertex Pharmaceuticals, Inc. Company Details
11.15.2 Vertex Pharmaceuticals, Inc. Business Overview
11.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Introduction
11.15.4 Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.15.5 Vertex Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Sickle Cell Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sickle Cell Anemia
Table 3. Key Players of Sickle Beta Thalassemia
Table 4. Key Players of Sickle Hemoglobin C Disease
Table 5. Global Sickle Cell Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sickle Cell Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sickle Cell Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Sickle Cell Disease Treatment Market Share by Regions (2016-2021)
Table 9. Global Sickle Cell Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Sickle Cell Disease Treatment Market Share by Regions (2022-2027)
Table 11. Sickle Cell Disease Treatment Market Trends
Table 12. Sickle Cell Disease Treatment Market Drivers
Table 13. Sickle Cell Disease Treatment Market Challenges
Table 14. Sickle Cell Disease Treatment Market Restraints
Table 15. Global Sickle Cell Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Sickle Cell Disease Treatment Market Share by Players (2016-2021)
Table 17. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2020)
Table 18. Ranking of Global Top Sickle Cell Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Sickle Cell Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle Cell Disease Treatment Product Solution and Service
Table 22. Date of Enter into Sickle Cell Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Sickle Cell Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Sickle Cell Disease Treatment Product
Table 65. AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Sickle Cell Disease Treatment Product
Table 70. Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Sickle Cell Disease Treatment Product
Table 75. Novartis Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Sickle Cell Disease Treatment Product
Table 80. Pfizer Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Sickle Cell Disease Treatment Product
Table 85. Baxter Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 86. Baxter Recent Development
Table 87. Emmaus Life Sciences Company Details
Table 88. Emmaus Life Sciences Business Overview
Table 89. Emmaus Life Sciences Sickle Cell Disease Treatment Product
Table 90. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 91. Emmaus Life Sciences Recent Development
Table 92. Bluebird bio Company Details
Table 93. Bluebird bio Business Overview
Table 94. Bluebird bio Sickle Cell Disease Treatment Product
Table 95. Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 96. Bluebird bio Recent Development
Table 97. Blood Therapeutics Company Details
Table 98. Blood Therapeutics Business Overview
Table 99. Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. Blood Therapeutics Recent Development
Table 101. Sangamo Therapeutics Company Details
Table 102. Sangamo Therapeutics Business Overview
Table 103. Sangamo Therapeutics Sickle Cell Disease Treatment Product
Table 104. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 105. Sangamo Therapeutics Recent Development
Table 106. Acceleron Pharma Company Details
Table 107. Acceleron Pharma Business Overview
Table 108. Acceleron Pharma Sickle Cell Disease Treatment Product
Table 109. Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 110. Acceleron Pharma Recent Development
Table 111. Arena Pharmaceuticals Company Details
Table 112. Arena Pharmaceuticals Business Overview
Table 113. Arena Pharmaceuticals Sickle Cell Disease Treatment Product
Table 114. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 115. Arena Pharmaceuticals Recent Development
Table 116. Alnylam Pharmaceuticals Company Details
Table 117. Alnylam Pharmaceuticals Business Overview
Table 118. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product
Table 119. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 120. Alnylam Pharmaceuticals Recent Development
Table 121. Sanofi Company Details
Table 122. Sanofi Business Overview
Table 123. Sanofi Sickle Cell Disease Treatment Product
Table 124. Sanofi Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 125. Sanofi Recent Development
Table 126. CRISPR Therapeutics Company Details
Table 127. CRISPR Therapeutics Business Overview
Table 128. CRISPR Therapeutics Sickle Cell Disease Treatment Product
Table 129. CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 130. CRISPR Therapeutics Recent Development
Table 131. Vertex Pharmaceuticals, Inc. Company Details
Table 132. Vertex Pharmaceuticals, Inc. Business Overview
Table 133. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Product
Table 134. Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
Table 135. Vertex Pharmaceuticals, Inc. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Sickle Cell Anemia Features
Figure 3. Sickle Beta Thalassemia Features
Figure 4. Sickle Hemoglobin C Disease Features
Figure 5. Global Sickle Cell Disease Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Sickle Cell Disease Treatment Report Years Considered
Figure 10. Global Sickle Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Sickle Cell Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Sickle Cell Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Sickle Cell Disease Treatment Market Share by Regions (2022-2027)
Figure 14. Global Sickle Cell Disease Treatment Market Share by Players in 2020
Figure 15. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatment Revenue in 2020
Figure 17. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 21. North America Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 22. North America Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 23. United States Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 27. Europe Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 28. Europe Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 29. Germany Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2016-2027)
Figure 39. China Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Sickle Cell Disease Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Sickle Cell Disease Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Sickle Cell Disease Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 62. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 63. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 64. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 65. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 66. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 67. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 68. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 69. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 70. Sanofi Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 71. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 72. Vertex Pharmaceuticals, Inc. Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs